David Gerring
Corporate Officer/Principal bei ARECOR THERAPEUTICS PLC
Vermögen: 273 464 $ am 31.03.2024
Profil
David Gerring has held positions as Vice President of Development at Arecor Ltd.
and Vice President of Business Development at Arecor Therapeutics Plc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARECOR THERAPEUTICS PLC
0,50% | 16.11.2022 | 154 626 ( 0,50% ) | 273 464 $ | 31.03.2024 |
Aktive Positionen von David Gerring
| Unternehmen | Position | Beginn |
|---|---|---|
| ARECOR THERAPEUTICS PLC | Corporate Officer/Principal | - |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARECOR THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
